Canada to throw out 13.6 million doses of AstraZeneca Covid vaccine

Canada is going to throw out about 13.6 million doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad

AstraZeneca, pharma, coronavirus, vaccine
AP Ottawa
2 min read Last Updated : Jul 06 2022 | 8:32 AM IST

Canada is going to throw out about 13.6 million doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.

Canada signed a contract with AstraZeneca in 2020 to get 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it, mostly between March and June 2021.

Following concerns in the spring of 2021 about rare but potentially fatal blood clots from AstraZeneca, Canada focused on using its ample supplies of the mRNA vaccines from Pfizer-BioNTech and Moderna.

In July 2021, Canada promised to donate the rest of its procured supply, about 17.7 million doses. But in a statement Tuesday, Health Canada said that despite efforts to meet that pledge, 13.6 million doses have expired and will have to be thrown out.

"Due to limited demand for the vaccine and recipient country challenges with distribution and absorption, they were not accepted?" the statement said.

In all, Canada donated 8.9 million doses of AstraZeneca vaccine 4.8 millon doses from its main supply and 4.1 million doses that it bought from the COVAX vaccine-sharing programme.

About 85 per cent of Canadians are considered fully vaccinated, compared with 61 per cent of the world's population, and just 16 per cent of people living in the world's poorest countries.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCanadaAstraZenecaCoronavirus Vaccine

First Published: Jul 06 2022 | 8:32 AM IST

Next Story